Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 4861 AL 4875

Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health

Vega IE, Cabrera LY, Wygant CM, Velez-Ortiz D, Counts SE.

J Alzheimers Dis. 2017;58(4):979-992. doi: 10.3233/JAD-161261.

Treatment options and considerations for hypertensive patients to prevent dementia

Hernandorena I, Duron E, Vidal JS, Hanon O.

Expert Opin Pharmacother. 2017 Jul;18(10):989-1000. doi: 10.1080/14656566.2017.1333599. Epub 2017 May 29.

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

Knezevic D, Mizrahi R.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):123-131. doi: 10.1016/j.pnpbp.2017.05.007. Epub 2017 May 19.

Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment

Devlin KN, Giovannetti T.

Neuropsychol Rev. 2017 Jun;27(2):101-123. doi: 10.1007/s11065-017-9348-2. Epub 2017 May 24.

Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study

Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE.

Alzheimer Dis Assoc Disord. 2017 Apr-Jun;31(2):107-113. doi: 10.1097/WAD.0000000000000202.

Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients

Wams EJ, Wilcock GK, Foster RG, Wulff K.

Curr Alzheimer Res. 2017;14(10):1030-1041. doi: 10.2174/1567205014666170523095634.

Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk

Efthymiou AG, Goate AM.

Mol Neurodegener. 2017 May 26;12(1):43. doi: 10.1186/s13024-017-0184-x.

Is Sleep Disruption a Risk Factor for Alzheimer's Disease?

Macedo AC, Balouch S, Tabet N.

J Alzheimers Dis. 2017;58(4):993-1002. doi: 10.3233/JAD-161287.

Down syndrome, increased risk of dementia and lipid disturbances

Kłosowska A, Ćwiklińska A, Kuchta A, Berlińska A, Jankowski M, Wierzba J.

Dev Period Med. 2017;21(1):69-73. doi: 10.34763/devperiodmed.20172101.6973.

Challenging Assumptions About African American Participation in Alzheimer Disease Trials

Kennedy RE, Cutter GR, Wang G, Schneider LS.

Am J Geriatr Psychiatry. 2017 Oct;25(10):1150-1159. doi: 10.1016/j.jagp.2017.04.013. Epub 2017 Apr 25.

Advanced Glycation End-Products Are Associated With the Presence and Severity of Paratonia in Early Stage Alzheimer Disease

Drenth H, Zuidema SU, Krijnen WP, Bautmans I, van der Schans C, Hobbelen H.

J Am Med Dir Assoc. 2017 Jul 1;18(7):636.e7-636.e12. doi: 10.1016/j.jamda.2017.04.004. Epub 2017 May 27.

Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease

Haberman RP, Branch A, Gallagher M.

Neurotherapeutics. 2017 Jul;14(3):662-676. doi: 10.1007/s13311-017-0541-z.

Psychosis and dementia: risk factor, prodrome, or cause?

Fischer CE, Agüera-Ortiz L.

Int Psychogeriatr. 2018 Feb;30(2):209-219. doi: 10.1017/S1041610217000874. Epub 2017 May 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias